71
Participants
Start Date
April 21, 2017
Primary Completion Date
August 31, 2018
Study Completion Date
August 31, 2018
SAN007 5% cream
5% EISO in a cream formulation applied twice a day for up to 28 days.
Placebo
A placebo cream containing the same components as the vehicle for the active intervention arm
SAN007 10% cream
10% EISO in a cream formulation applied twice a day for up to 28 days.
J&S Sudies Pharmaceutical, Bryan
Progressive Clinical Research, San Antonio
Texas Dermatology and Laser Specialists, San Antonio
Clinical Trials of Texas, San Antonio
DermResearch, Austin
Collaborators (3)
ClinDatrix, Inc.
INDUSTRY
Texas Dermatology and Laser Specialists
UNKNOWN
Clinical Trials of Texas, Inc.
OTHER
Derm Research, PLLC
OTHER
Progressive Clinical Research
OTHER
U.S. Dermatology Partners Bryan
UNKNOWN
Santalis Pharmaceuticals, Inc.
INDUSTRY